HHS ASPR Launches Therapeutics Distribution Locations Interactive Map

COVID-19
​The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has announced the launch of the HHS Protect Public Data Hub displaying the locations that have received shipments of the COVID-19 monoclonal antibody (mAb) therapeutics under the U.S. Food and Drug Administration Emergency Use Authorization (EUA) authority.   

The mAb therapeutic treatments have shipped nationwide. However, the shipment locations displayed on the therapeutics distribution locations interactive map include the states that have opted to have their locations displayed on the public website.   

Supply of mAbs is not an issue, but rather there is an underutilization of the therapeutics. HHS ASPR has created a frequently asked questions webpage to help long term care facilities (LTCFs) navigate the process of getting the therapeutics into centers and to the vulnerable populations they serve. Through the Special Projects for Equitable and Efficient Distribution (SPEED) program, HHS ASPR is working with the American Society of Consultant Pharmacists (ASCP) and AMDA (the Society for Post-Acute and Long-Term Care Medicine) to streamline allocation of the mAbs to every LTCF – including nursing homes and assisted living communities – that require treatment. ASCP and AMDA have produced a readiness document for pharmacies and LTCFs.   

In addition, home infusion can also be utilized to facilitate treatment. The National Home Infusion Association (NHIA) has provided a PDF listing of home infusion providers in the mAb pilot program.  LTCFs are encouraged to reach out to their current pharmacy to see if they are already participating in the federal allocation of mAbs. If they are not participating but are interested, they should submit their pharmacy name, address, contact person/information, and Amerisource Bergan customer identification number or pharmacy license number to Chad Worz. Contact ASPRStakeholder@hhs.gov​ for more information on SPEED or to find out how to participate in the SPEED program.